| Vaghenag Vahe Tarpinian, MD | |
|
104 S 2nd St, Bangor, PA 18013-2504 | |
| (610) 588-3133 | |
| (610) 588-6251 |
| Full Name | Vaghenag Vahe Tarpinian |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 104 S 2nd St, Bangor, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700886181 | NPI | - | NPPES |
| 001556643005 | Medicaid | PA | |
| 821939 | Other | PA | PENNSYLVANIA BLUE SHIELD |
| 0015566430013 | Medicaid | PA | |
| 50081521 | Other | PA | CAPITAL BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD038095-E (Pennsylvania) | Primary |
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902347438 PECOS PAC ID: 2860688728 Enrollment ID: O20170524000169 |
News Archive
"Hype" surrounding a study published in the Aug. 24 edition of the journal Nature describing a technique that could derive human embryonic stem cells without destroying the embryo is harming chances of approving legislation to expand federal funding for embryonic stem cell research, CQ HealthBeat reports (Reichard, CQ HealthBeat, 9/6).
"An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease," according to a study "presented at the Bill & Melinda Gates Foundation's Malaria Forum conference in Seattle and published simultaneously in the New England Journal of Medicine" on Tuesday, Reuters reports.
A new high-tech medical device to make brain surgery safer has been developed by researchers at the University of Adelaide.
Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) released unaudited preliminary financial results for the first quarter of fiscal year 2015.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vaghenag Vahe Tarpinian, MD 104 S 2nd St, Bangor, PA 18013-2504 Ph: (610) 588-3133 | Vaghenag Vahe Tarpinian, MD 104 S 2nd St, Bangor, PA 18013-2504 Ph: (610) 588-3133 |
News Archive
"Hype" surrounding a study published in the Aug. 24 edition of the journal Nature describing a technique that could derive human embryonic stem cells without destroying the embryo is harming chances of approving legislation to expand federal funding for embryonic stem cell research, CQ HealthBeat reports (Reichard, CQ HealthBeat, 9/6).
"An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease," according to a study "presented at the Bill & Melinda Gates Foundation's Malaria Forum conference in Seattle and published simultaneously in the New England Journal of Medicine" on Tuesday, Reuters reports.
A new high-tech medical device to make brain surgery safer has been developed by researchers at the University of Adelaide.
Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) released unaudited preliminary financial results for the first quarter of fiscal year 2015.
› Verified 4 days ago
Nicholas M Romano Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 104 S 2nd St, Bangor, PA 18013 Phone: 610-588-3133 Fax: 610-588-5138 |